Biondo Investment Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-76,169
Closed -$18.7M 74
2022
Q3
$18.7M Sell
76,169
-655
-0.9% -$177K 4.31% 4
2022
Q2
$19M Buy
76,824
+791
+1% +$213K 4.19% 5
2022
Q1
$25.2M Sell
76,033
-1,670
-2% -$514K 4.44% 5
2021
Q4
$27.9M Sell
77,703
-5,448
-7% -$1.84M 4.65% 5
2021
Q3
$27.1M Buy
83,151
+765
+0.9% +$259K 4.65% 4
2021
Q2
$25.7M Sell
82,386
-80
-0.1% -$24.5K 4.42% 6
2021
Q1
$26.3M Buy
82,466
+2,152
+3% +$689K 5.23% 4
2020
Q4
$26M Buy
80,314
+1,055
+1% +$292K 4.99% 5
2020
Q3
$22M Sell
79,259
-275
-0.3% -$79.2K 4.76% 5
2020
Q2
$19.2M Buy
79,534
+1,910
+2% +$384K 4.85% 4
2020
Q1
$11.3M Sell
77,624
-866
-1% -$144K 3.73% 8
2019
Q4
$13.4M Buy
78,490
+15,655
+25% +$2.9M 3.09% 10
2019
Q3
$11.2M Buy
62,835
+296
+0.5% +$64K 2.86% 8
2019
Q2
$16.3M Sell
62,539
-1,376
-2% -$365K 3.86% 6
2019
Q1
$18.3M Sell
63,915
-1,734
-3% -$576K 4.58% 4
2018
Q4
$21.3M Buy
65,649
+500
+0.8% +$174K 6.44% 3
2018
Q3
$29.3M Sell
65,149
-4,102
-6% -$1.62M 6.96% 4
2018
Q2
$28.3M Sell
69,251
-3,648
-5% -$1.32M 7.14% 3
2018
Q1
$21.2M Buy
72,899
+3,105
+4% +$787K 5.53% 4
2017
Q4
$13.1M Buy
69,794
+3,260
+5% +$609K 3.3% 7
2017
Q3
$11.2M Sell
66,534
-605
-0.9% -$91.5K 3.09% 9
2017
Q2
$9.62M Buy
+67,139
New +$9.02M 2.78% 10
2017
Q1
Sell
-30,724
Closed -$3.46M 85
2016
Q4
$3.46M Sell
30,724
-4,685
-13% -$543K 1.15% 33
2016
Q3
$4.55M Buy
+35,409
New +$4.24M 1.54% 21

Other funds holding ABMD

Biondo Investment Advisors's ABMD Position: Q4 2022 in Review

Biondo Investment Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 76,169 shares — an estimated $18.7M sold.

Biondo Investment Advisors first reported a position in ABMD in Q3 2016 and held it in 24 quarters. The position peaked at $29.3M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Biondo Investment Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Biondo Investment Advisors sold 76,169 Abiomed Inc shares in Q4 2022, an estimated $18.7M.
  • Biondo Investment Advisors first reported a position in Abiomed Inc in Q3 2016 and held it in 24 quarters.
  • Biondo Investment Advisors's Abiomed Inc position peaked at $29.3M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Biondo Investment Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.